Origin Energy Limited in energy assets mega sale

Origin Energy Limited (ASX:ORG) today announced it would spin-off its upstream gas business into an IPO in 2017.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Still under pressure from low oil prices and a heavy debt load, gas producer and energy retailer Origin Energy Limited (ASX: ORG) announced this morning that it would spin off its upstream gas business into an Initial Public Offer (IPO) – to create a new company – in 2017.

As Origin lacks the capital to invest into these largely untapped assets, an IPO is thought to be the best decision for all involved. Origin can use the proceeds of the sale to close out some contracts and shore up its balance sheet, while the new company ('NewCo') will benefit from dedicated management and easier access to capital.

NewCo will end up with many of Origin's prime prospects, including Origin's share in the Waitsia, Otway, and BassGas fields plus a number of other projects. After completion of the IPO, NewCo is expected to have around 948 PetaJoules (PJe) in 2P reserves as well as around 75 PJe in annual production.

Contracts will ensure NewCo's earnings in the short term, and the sale is expected to grow Origin's Earnings Per Share from 2019 as well as improve its return on invested capital. Origin will retain its share of its mega APLNG project as well as the Ironbark, Browse, and Betaloo basins.

The proposed IPO will not require shareholder approval, but Origin did not state how it would account for the interests of shareholders – perhaps by offering them shares in NewCo first. Here's hoping that Origin conducts the IPO in a way that is fair for all existing shareholders.

NewCo looks interesting, and at this point I would probably prefer to own it instead of Origin. Without the IPO documents, there's no point making an investment decision yet – but you can expect detailed coverage from us when the documents come out next year.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »